 EXETER, N.H.--BUSINESS WIRE--Vapotherm, Inc. NYSE: VAPO, Vapotherm or the Company, a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy products, which are used to treat patients of all ages suffering from respiratory distress, today announced an update to its fourth quarter and fiscal year 2020 revenue guidance given on November 4, 2020. Fourth Quarter and Fiscal Year 2020 Outlook For fourth quarter 2 